MBLY vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

MBLY

40.6
AI Score
VS
MBLY Wins

PATH

28.7
AI Score

Investment Advisor Scores

MBLY

41score
Recommendation
HOLD

PATH

29score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MBLY PATH Winner
Forward P/E 17.5131 19.6078 MBLY
PEG Ratio 0.2917 0.5603 MBLY
Revenue Growth 0.4% 17.3% PATH
Earnings Growth 99.7% 105.7% PATH
Tradestie Score 40.6/100 28.7/100 MBLY
Profit Margin -201.5% 19.6% PATH
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MBLY

Relative Price Performance (Last 90 Days)

MBLY 1M: +20.9% · 3M: -7.9% PATH 1M: +60.7% · 3M: +55.1%

Current Technical Phase

MBLY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.5 · Price: $9.03

PATH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.5% over 20 days), RSI 70

RSI (14): 69.7 · Price: $16.39

Fundamentals Snapshot

Metric MBLY PATH
Market Cap
Forward P/E 18.6 20.9
Trailing P/E 25.9
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.5% 0.8%
Operating Margin -0.1% 0.1%
EPS -4.97 0.61
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MBLY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.